Citrullinated histone H3, a marker for neutrophil extracellular traps, is associated with poorer prognosis in recessive dystrophic epidermolysis bullosa patients with cutaneous squamous cell carcinoma

被引:0
|
作者
Ragot, H. [4 ]
Gaucher, S. [2 ,4 ]
Titeux, M. [4 ]
des Claustres, M. Bonnet [4 ]
Basset, J. [4 ]
Battistella, M. [1 ]
Bourrat, E. [3 ]
Hovnanian, A. [2 ,3 ,4 ,5 ]
机构
[1] St Louis Hosp, Dept Pathol, Paris, France
[2] Univ Paris, Paris, France
[3] St Louis Hosp, Reference Ctr Genodermatoses, Paris, France
[4] Imagine Inst, Lab Genet Skin Dis, Paris, France
[5] Hop Necker Enfants Malad, Dept Genet, Paris, France
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
102
引用
收藏
页码:S17 / S17
页数:1
相关论文
共 50 条
  • [31] Fibroblast-Derived Dermal Matrix Drives Development of Aggressive Cutaneous Squamous Cell Carcinoma in Patients with Recessive Dystrophic Epidermolysis Bullosa
    Yi-Zhen Ng
    Pourreyron, Celine
    Salas-Alanis, Julio C.
    Dayal, Jasbani H. S.
    Cepeda-Valdes, Rodrigo
    Yan, Wenfei
    Wright, Sheila
    Chen, Mei
    Fine, Jo-David
    Hogg, Fiona J.
    McGrath, John A.
    Murrell, Dedee F.
    Leigh, Irene M.
    Lane, E. Birgit
    South, Andrew P.
    CANCER RESEARCH, 2012, 72 (14) : 3522 - 3534
  • [32] Rigosertib demonstrates considerable efficacy and safety in the treatment of advanced/metastatic cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa
    Laimer, M.
    South, A.
    Yang, H. Y.
    Banner, L.
    Mayr, E.
    Kitzmueller, S.
    Parris, M.
    Arora, M.
    Bauer, J.
    Nikbakht, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S50 - S50
  • [33] SQUAMOUS-CELL CARCINOMA SECONDARY TO RECESSIVE DYSTROPHIC EPIDERMOLYSIS-BULLOSA - A REPORT OF 4 PATIENTS WITH 17 PRIMARY CUTANEOUS MALIGNANCIES
    NEWMAN, C
    WAGNER, RF
    TYRING, SK
    SPIGEL, GT
    JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1992, 18 (04): : 301 - 305
  • [34] Recessive dystrophic epidermolysis bullosa-associated squamous-cell carcinoma: An enigmatic entity with complex pathogenesis
    Rodeck, Ulrich
    Uitto, Jouni
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (10) : 2295 - 2296
  • [35] Oral rigosertib demonstrates preliminary efficacy in the treatment of recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell
    Banner, L.
    Hosler, L.
    Parris, M.
    Gelder, M.
    Laimer, M.
    Bauer, J.
    South, A.
    Nikbakht, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S105 - S105
  • [36] Validation of an enzyme-linked immunosorbent assay for the quantification of citrullinated histone H3 as a marker for neutrophil extracellular traps in human plasma
    Thalin, Charlotte
    Daleskog, Maud
    Goransson, Sophie Paues
    Schatzberg, Daphne
    Lasselin, Julie
    Laska, Ann-Charlotte
    Kallner, Anders
    Helleday, Thomas
    Wallen, Hakan
    Demers, Melanie
    IMMUNOLOGIC RESEARCH, 2017, 65 (03) : 706 - 712
  • [37] Validation of an enzyme-linked immunosorbent assay for the quantification of citrullinated histone H3 as a marker for neutrophil extracellular traps in human plasma
    Charlotte Thålin
    Maud Daleskog
    Sophie Paues Göransson
    Daphne Schatzberg
    Julie Lasselin
    Ann-Charlotte Laska
    Anders Kallner
    Thomas Helleday
    Håkan Wallén
    Mélanie Demers
    Immunologic Research, 2017, 65 : 706 - 712
  • [38] Heterogeneous addiction to transforming growth factor-beta signalling in recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinoma
    Dayal, J. H. S.
    Mason, S. M.
    Salas-Alanis, J. C.
    McGrath, J. A.
    Taylor, R. G.
    Mellerio, J. E.
    Blyth, K.
    South, A. P.
    Inman, G. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (04) : 697 - 708
  • [39] Differential regulation of miR-200b in squamous cell carcinoma of patients with recessive dystrophic epidermolysis bullosa
    Illmer, J.
    Wimmer, M.
    Zauner, R.
    Ablinger, M.
    Bischof, J.
    Tober, V.
    Atzmueller, S.
    Proell, J.
    Bauer, J.
    Wally, V.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (12) : S262 - S262
  • [40] Variable Outcome of Immunotherapy in Advanced Multiple Cutaneous Squamous Cell Carcinomas in Two Patients with Recessive Dystrophic Epidermolysis Bullosa
    Trefzer, Laura
    Hess, Maria E.
    Scholten, Lena
    Technau-hafsi, Kristin
    Meiss, Frank
    Boerries, Melanie
    Has, Cristina
    Rafei-shamsabadi, David
    ACTA DERMATO-VENEREOLOGICA, 2023, 103